[go: up one dir, main page]

HUP0200418A2 - Új citokin zalpha 11 ligandum - Google Patents

Új citokin zalpha 11 ligandum

Info

Publication number
HUP0200418A2
HUP0200418A2 HU0200418A HUP0200418A HUP0200418A2 HU P0200418 A2 HUP0200418 A2 HU P0200418A2 HU 0200418 A HU0200418 A HU 0200418A HU P0200418 A HUP0200418 A HU P0200418A HU P0200418 A2 HUP0200418 A2 HU P0200418A2
Authority
HU
Hungary
Prior art keywords
ligand
human cytokine
zalpha
receptor
protein
Prior art date
Application number
HU0200418A
Other languages
English (en)
Inventor
Stacey R. Dillon
Donald C. Foster
Jane A. Gross
Angela K. Hammond
Richard D. Holly
Janet V. Johnston
Andrew J. Nelson
Julia E. Novak
Scott R. Presnell
Cindy A. Sprecher
Original Assignee
Zymogenetics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27385745&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0200418(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zymogenetics, Inc. filed Critical Zymogenetics, Inc.
Publication of HUP0200418A2 publication Critical patent/HUP0200418A2/hu
Publication of HUP0200418A3 publication Critical patent/HUP0200418A3/hu
Publication of HU229148B1 publication Critical patent/HU229148B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgyát zalpha11 ligandum polinukleotid és polipeptidmolekulák képezik. A zalpha11 ligandum egy új citokin. Apolipeptideket hematopoietikus sejtek in vitro és in vivoszaporodásának és/vagy fejlődésének stimulálására használjuk. Atalálmány tárgát képezik továbbá a fehérje előállítási módszerei, afehérje használata és az ellene készített ellenanyagok. Ó
HU0200418A 1999-03-09 2000-03-09 Human cytokine as ligand of the zalpha receptor and uses thereof HU229148B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US26490899A 1999-03-09 1999-03-09
US26599299A 1999-03-11 1999-03-11
US14201399P 1999-07-01 1999-07-01
PCT/US2000/006067 WO2000053761A2 (en) 1999-03-09 2000-03-09 Human cytokine as ligand of the zalpha receptor and uses thereof

Publications (3)

Publication Number Publication Date
HUP0200418A2 true HUP0200418A2 (hu) 2002-05-29
HUP0200418A3 HUP0200418A3 (en) 2003-12-29
HU229148B1 HU229148B1 (en) 2013-09-30

Family

ID=27385745

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200418A HU229148B1 (en) 1999-03-09 2000-03-09 Human cytokine as ligand of the zalpha receptor and uses thereof

Country Status (23)

Country Link
EP (3) EP2295577A3 (hu)
JP (1) JP4405686B2 (hu)
KR (1) KR100743640B1 (hu)
CN (5) CN1827639A (hu)
AT (1) ATE377076T1 (hu)
AU (2) AU777842B2 (hu)
BR (1) BR0008772B1 (hu)
CA (1) CA2366921C (hu)
CZ (1) CZ302921B6 (hu)
DE (1) DE60036930T2 (hu)
DK (1) DK1165791T3 (hu)
ES (1) ES2295019T3 (hu)
HU (1) HU229148B1 (hu)
IL (5) IL145288A0 (hu)
MX (1) MXPA01009074A (hu)
NO (2) NO331551B1 (hu)
NZ (1) NZ514708A (hu)
PL (1) PL207350B1 (hu)
PT (1) PT1165791E (hu)
RU (1) RU2346951C2 (hu)
UA (1) UA84387C2 (hu)
WO (1) WO2000053761A2 (hu)
ZA (1) ZA017370B (hu)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7198789B2 (en) 1998-03-17 2007-04-03 Genetics Institute, Llc Methods and compositions for modulating interleukin-21 receptor activity
US6057128A (en) 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
US7189400B2 (en) 1998-03-17 2007-03-13 Genetics Institute, Llc Methods of treatment with antagonists of MU-1
MXPA01009074A (es) * 1999-03-09 2002-03-27 Zymogenetics Inc Nuevo ligando zalfa11 de citocina.
WO2003028630A2 (en) 2001-10-04 2003-04-10 Genetics Institute Llc. Methods and compositions for modulating interleukin-21 receptor activity
AU2002336676A1 (en) 2001-11-05 2003-05-19 Zymogenetics, Inc Il-21 antagonists
AU2003243415A1 (en) * 2002-06-07 2003-12-22 Zymogenetics, Inc. Use of il-21 in cancer and other therapeutic applications
MXPA05000655A (es) 2002-07-15 2006-02-22 Harvard College Metodos y composiciones para modular el desarrollo y la funcion de las celulas t helper (th).
CA2501807A1 (en) * 2002-10-11 2004-04-22 Novo Nordisk A/S Treatment of allergic conditions by use of il 21
RU2005113992A (ru) * 2002-10-11 2005-10-27 Ново Нордиск А/С (DK) Лечение аллергических состояний с использованием il-21
RU2354703C2 (ru) * 2002-12-13 2009-05-10 Займодженетикс, Инк. Продуцирование il-21 в прокариотических клетках-хозяевах
RU2005131852A (ru) 2003-03-14 2006-04-20 Уайт (Us) Антитела против человеческого рецептора il-21 и их применение
US20050124044A1 (en) * 2003-06-19 2005-06-09 Cunningham Mark R. Interleukin-21 analogs
DE602004031341D1 (de) 2003-07-21 2011-03-24 Transgene Sa Multifunktionelle cytokine
DE602004031681D1 (de) 2003-07-21 2011-04-14 Transgene Sa Multifunktionelle Cytokine
CA2538083A1 (en) * 2003-09-25 2005-04-07 Zymogenetics, Inc. Methods of treating autoimmune diseases using il-21
US20060228331A1 (en) * 2003-10-10 2006-10-12 Novo Nordisk A/S IL-21 Derivatives and variants
CN102516386A (zh) * 2003-10-10 2012-06-27 诺沃挪第克公司 Il-21衍生物
ES2428358T3 (es) 2003-10-17 2013-11-07 Novo Nordisk A/S Terapia de combinación
EP1708737A2 (en) * 2004-01-15 2006-10-11 Novo Nordisk A/S Use of interleukin-21 for the treatment of autoimmune diseases and allograft rejection
EP2033662B1 (en) 2004-01-21 2012-10-17 Novo Nordisk Health Care AG Transglutaminase mediated conjugation of peptides
GT200600148A (es) 2005-04-14 2006-11-22 Metodos para el tratamiento y la prevencion de fibrosis
RU2412199C2 (ru) 2005-04-18 2011-02-20 Ново Нордиск А/С Варианты ил-21
PL1963369T3 (pl) * 2005-11-28 2013-10-31 Zymogenetics Inc Antagoniści IL-21
CA2666426A1 (en) 2006-10-26 2008-05-02 Novo Nordisk A/S Il-21 variants
EP2109620B1 (en) 2006-12-21 2012-08-22 Novo Nordisk A/S Interleukin-21 variants with altered binding to the il-21 receptor
EP3103813A1 (en) 2007-12-07 2016-12-14 ZymoGenetics, Inc. Anti-human il-21 monoclonal antibodies
AR071885A1 (es) 2008-05-23 2010-07-21 Wyeth Corp Proteinas de union al receptor de interleuquina 21
JP2011520989A (ja) 2008-05-23 2011-07-21 ワイス・エルエルシー インターロイキン−２１受容体の結合性タンパク質を利用する治療法
CA2739357A1 (en) 2008-09-23 2010-04-08 Wyeth Llc Methods for predicting production of activating signals by cross-linked binding proteins
CN102021196B (zh) * 2009-11-20 2013-06-26 上海杰隆生物工程股份有限公司 毕赤酵母生产重组人白细胞介素21的方法
CA2877933A1 (en) 2012-06-27 2014-01-03 Yuri Bushkin Rapid assays for t-cell activation by rna measurements using flow cytometry
WO2015110930A1 (en) 2014-01-24 2015-07-30 Pfizer Inc. Modified interleukin 21 receptor proteins
EP2982693A1 (en) * 2014-08-07 2016-02-10 Affimed Therapeutics AG CD3 binding domain
EP4149539A4 (en) * 2020-05-14 2024-06-12 Metaclipse Therapeutics Corporation COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF SARS-COV-2 INFECTION
US12012441B2 (en) 2020-10-26 2024-06-18 Neptune Biosciences Llc Engineered human IL-21 cytokines and methods for using the same
CN112662694A (zh) * 2020-12-25 2021-04-16 康九生物科技(长春)有限公司 一种麦芽糖结合蛋白、麦芽糖结合蛋白表达载体、重组工程菌及其应用
US20250000946A1 (en) * 2021-09-26 2025-01-02 WuXi Biologics Ireland Limited Il-2 variants and fusion proteins thereof

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4615974A (en) 1981-08-25 1986-10-07 Celltech Limited Yeast expression vectors
US4579821A (en) 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
US4656134A (en) 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4486533A (en) 1982-09-02 1984-12-04 St. Louis University Filamentous fungi functional replicating extrachromosomal element
US4599311A (en) 1982-08-13 1986-07-08 Kawasaki Glenn H Glycolytic promotersfor regulated protein expression: protease inhibitor
US4977092A (en) 1985-06-26 1990-12-11 Amgen Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US5139936A (en) 1983-02-28 1992-08-18 Collaborative Research, Inc. Use of the GAL1 yeast promoter
US4661454A (en) 1983-02-28 1987-04-28 Collaborative Research, Inc. GAL1 yeast promoter linked to non galactokinase gene
US4650764A (en) 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
US4931373A (en) 1984-05-25 1990-06-05 Zymogenetics, Inc. Stable DNA constructs for expression of α-1 antitrypsin
US4766073A (en) 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
EP0184576B1 (en) 1984-12-06 1990-06-27 Fina Research S.A. Promoters for the expression of foreign genes in yeast, plasmids comprising them, and uses thereof for the production of polypeptides
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4935349A (en) 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
GB8611832D0 (en) 1986-05-15 1986-06-25 Holland I B Polypeptide
US4980289A (en) 1987-04-27 1990-12-25 Wisconsin Alumni Research Foundation Promoter deficient retroviral vector
US5063154A (en) 1987-06-24 1991-11-05 Whitehead Institute For Biomedical Research Pheromone - inducible yeast promoter
US5567584A (en) 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
ATE140963T1 (de) 1988-01-22 1996-08-15 Zymogenetics Inc Verfahren zur herstellung von sekretierten rezeptoranalogen
US4956288A (en) 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5162228A (en) 1988-12-28 1992-11-10 Takeda Chemical Industries, Ltd. Gylceraldehyde-3-phosphate dehydrogenase gene and promoter
US5124263A (en) 1989-01-12 1992-06-23 Wisconsin Alumni Research Foundation Recombination resistant retroviral helper cell and products produced thereby
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5162222A (en) 1989-07-07 1992-11-10 Guarino Linda A Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
US5298418A (en) 1991-09-16 1994-03-29 Boyce Thompson Institute For Plant Research, Inc. Cell line isolated from larval midgut tissue of Trichoplusia ni
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
CA2144651A1 (en) 1992-09-14 1994-03-31 Timothy J. Miller Immortalized cells and uses therefor
WO1995007358A1 (en) 1993-07-30 1995-03-16 University Of Medicine & Dentistry Of New Jersey Efficient gene transfer into primary lymphocytes
RU2220979C2 (ru) * 1993-08-12 2004-01-10 Иммьюнекс Корпорейшн ПОЛИПЕПТИД ЛИГАНДА flt3 (ВАРИАНТЫ), ПОЛИНУКЛЕОТИД(ВАРИАНТЫ), ЭКСПРЕССИРУЮЩИЙ ВЕКТОР(ВАРИАНТЫ), ЛИНИЯ КЛЕТОК СНО (ВАРИАНТЫ), СПОСОБ ПРОДУЦИРОВАНИЯ ПОЛИПЕПТИДА ЛИГАНДА flt3 (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ (ВАРИАНТЫ)
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5795966A (en) * 1995-02-22 1998-08-18 Immunex Corp Antagonists of interleukin-15
AU1158297A (en) 1995-11-09 1997-05-29 Zymogenetics Inc. Production of gad65 in methylotrophic yeast
WO1998002565A1 (en) 1996-07-17 1998-01-22 Zymogenetics, Inc. TRANSFORMATION OF $i(PICHIA METHANOLICA)
IL128072A0 (en) 1996-07-17 1999-11-30 Zymogenetics Inc Preparation of pichia methanolica auxotrophic mutants
JP4215172B2 (ja) 1996-12-03 2009-01-28 アムジェン フレモント インク． 複数のＶ▲下Ｈ▼およびＶ▲下κ▼領域を含むヒトＩｇ遺伝子座を有するトランスジェニック哺乳動物、ならびにそれから産生される抗体
IL122818A0 (en) * 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
US6057128A (en) * 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
MXPA01009074A (es) * 1999-03-09 2002-03-27 Zymogenetics Inc Nuevo ligando zalfa11 de citocina.
US9418201B1 (en) 2015-11-19 2016-08-16 International Business Machines Corporation Integration of functional analysis and common path pessimism removal in static timing analysis

Also Published As

Publication number Publication date
PL351160A1 (en) 2003-03-24
NZ514708A (en) 2005-01-28
EP1165791A2 (en) 2002-01-02
ES2295019T3 (es) 2008-04-16
JP4405686B2 (ja) 2010-01-27
CN1927883A (zh) 2007-03-14
DE60036930D1 (de) 2007-12-13
EP1165791B1 (en) 2007-10-31
CA2366921C (en) 2013-12-17
CZ20013184A3 (cs) 2002-04-17
CN102406937A (zh) 2012-04-11
NO20014364D0 (no) 2001-09-07
JP2002537839A (ja) 2002-11-12
IL145288A0 (en) 2002-06-30
HUP0200418A3 (en) 2003-12-29
RU2004126135A (ru) 2006-02-10
WO2000053761A2 (en) 2000-09-14
AU2005200240A1 (en) 2005-02-17
EP2295577A2 (en) 2011-03-16
NO20111085L (no) 2001-11-09
CN101575377B (zh) 2012-12-26
KR100743640B1 (ko) 2007-07-27
PL207350B1 (pl) 2010-12-31
CN101575377A (zh) 2009-11-11
IL145288A (en) 2010-11-30
BR0008772A (pt) 2002-05-07
IL207424A (en) 2013-04-30
ZA017370B (en) 2002-06-26
PT1165791E (pt) 2008-01-16
CN1927883B (zh) 2011-09-21
AU3731200A (en) 2000-09-28
IL195713A (en) 2010-11-30
EP1881070A3 (en) 2008-03-05
MXPA01009074A (es) 2002-03-27
KR20010103794A (ko) 2001-11-23
UA84387C2 (ru) 2008-10-27
EP1881070A2 (en) 2008-01-23
DE60036930T2 (de) 2008-10-09
EP1881070B1 (en) 2012-10-03
AU777842B2 (en) 2004-11-04
CN100500846C (zh) 2009-06-17
HU229148B1 (en) 2013-09-30
ATE377076T1 (de) 2007-11-15
CA2366921A1 (en) 2000-09-14
IL207403A (en) 2012-03-29
NO20014364L (no) 2001-11-09
NO331551B1 (no) 2012-01-23
EP2295577A3 (en) 2012-08-08
CZ302921B6 (cs) 2012-01-18
RU2346951C2 (ru) 2009-02-20
WO2000053761A3 (en) 2000-12-21
CN1827639A (zh) 2006-09-06
BR0008772B1 (pt) 2011-11-01
CN1378595A (zh) 2002-11-06
DK1165791T3 (da) 2008-02-11

Similar Documents

Publication Publication Date Title
HUP0200418A2 (hu) Új citokin zalpha 11 ligandum
HUP0402162A2 (hu) A humán angiopoietin-2 specifikus kötőanyagai
ZA975851B (en) Hepatocyte grown factor receptor agonists and uses thereof
ZA200405388B (en) Binding proteins as biosensors
ZA200405390B (en) Entrapped binding proteins as biosensors
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
ATE265219T1 (de) Verwendung von cxcr4 antagonisten zur behandlung von krebs und autoimmunkrankheiten
CY1118115T1 (el) Υποδοχεας κυτοκινης zcytor17
HUP0100436A2 (hu) Emlős citokinszerű polipeptid-10
DE60332277D1 (de) Verabreichung von sirnas
BRPI0507680A (pt) partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas
ATE440951T1 (de) Verlängerte cdns, die für sekretierte proteine kodieren
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
HUP0103758A2 (hu) Neurotróf faktorok
ZA200405389B (en) Binding proteins as biosensors
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
AU2002241533A1 (en) Cytonkine receptor zcytor19
NO20011460L (no) Cytokinreseptor zalphall
BR0212070A (pt) ácidos nucléicos e polipeptìdeos bv8 com atividade mitogênica
BR9712793A (pt) Fatores homólogos (fhfs) ao fator do desenvolvimento de fibroblasto e métodos de uso
EP2116616A3 (en) Genes differentially expressed in activated T cells and uses thereof
HUP0400340A2 (hu) Polipeptidek immunogenitásának csökkentésére szolgáló eljárások
ATE363072T1 (de) Monoklonaler antikörper gegen mxa und mxb
ATE420890T1 (de) Isoleucyl-valyl-threonyl-asparaginyl-threonyl- threonin (ivtntt) enthaltende biologisch wirksame peptide
FI954889L (fi) Proteiini, jolla on TPO-aktiviteetti

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees